Funding for Global Cancer Research and Training
The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.
Sort the table below for current funding opportunities for global cancer research and research training.
Learn more about grants and funding from the National Institutes of Health.
Current Funding Opportunities
|Title||Announcement Number||Opening Date||Due Date||Additional Resources|
|Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)||PAR-23-318||02/22/2023||03/22/2024||Letter of Intent Due Date:
February 22, 2024
|Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control||NIH/NCI 456||8/28/2023||11/14/2023||Apply for this topic on the Contract Proposal Submission (eCPS) website|
|Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)||RFA-CA-23-033||11/15/2023||12/15/2023||Pre-Application Webinar for RFA-CA-23-033|
|Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings||NOT-CA-23-078||7/27/2023||11/18/2025||
First available due date: 10/17/2023
|Co-infection and Cancer (R21 Clinical Trial Not Allowed)||PAR-23-056||12/14/2022||11/16/2025|
|Co-infection and Cancer (R01 Clinical Trial Not Allowed)||PAR-23-055||12/14/2022||11/05/2025|
|Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)||PAR-22-085||5/05/2022||5/08/2025||Reissue of PAR-19-193|
|Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)||PAR-22-086||5/16/2022||5/08/2025||Reissue of PAR-19-194|
|Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions||NOT-DE-21-010||08/06/2021||09/10/2024|
|Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings||NOT-CA-21-062||07/23/2021||09/07/2024||This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.|
|Notice of Special Interest: Academy of Finland (AKA) – National Institutes of Health (NIH) Partnership Program||NOT-OD-21-021||11/13/2020||01/08/2024|
|Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments||NOT-CA-22-038||10/05/2022||05/08/2024||Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health FOAs:
Reissue of NOT-CA-20-025
|Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)||PAR-22-105||05/15/2022||05/08/2025|
|Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)||PAR-22-106||05/16/2022||05/08/2025|
|Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)||PAR-22-109||05/16/2022||05/08/2025|
Explore cancer research programs and research training offered and funded through CGH.